Woodline Partners LP Uro Gen Pharma Ltd. Transaction History
Woodline Partners LP
- $11 Billion
- Q3 2024
A detailed history of Woodline Partners LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Woodline Partners LP holds 305,642 shares of URGN stock, worth $3.43 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
305,642
Previous 303,740
0.63%
Holding current value
$3.43 Million
Previous $5.1 Million
23.84%
% of portfolio
0.04%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
128Shares Held
35.9MCall Options Held
22KPut Options Held
93.8K-
Rtw Investments, LP New York, NY3.79MShares$42.5 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.74MShares$41.9 Million0.09% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$25.8 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$24.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.18MShares$24.5 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $255M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...